2000
DOI: 10.1002/1529-0131(200003)43:3<689::aid-anr27>3.0.co;2-u
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative radioligand assays using de novo–synthesized recombinant autoantigens in connective tissue diseases: New tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases

Abstract: These highly sensitive, specific, and quantitative RLAs represent new tools for the detection of autoantibodies to RNP antigens in rheumatic diseases, and may be useful for (differential) diagnosis in clinical practice.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
26
2

Year Published

2001
2001
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 41 publications
(31 citation statements)
references
References 46 publications
(23 reference statements)
3
26
2
Order By: Relevance
“…Radioligand assay detects natural conformational epitope of antigens, while the immunoblotting method may detect denatured antigen. It has already been shown that radioligand assay detects autoantibodies even against conformational antigens [17,18]. O'Dwyer et al [6] purified enolase using goat polyclonal antienolase antibodies (C-19) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), but in our study these antibodies could not detect recombinant alpha-enolase by radioligand assay (data not shown).…”
Section: Discussioncontrasting
confidence: 59%
“…Radioligand assay detects natural conformational epitope of antigens, while the immunoblotting method may detect denatured antigen. It has already been shown that radioligand assay detects autoantibodies even against conformational antigens [17,18]. O'Dwyer et al [6] purified enolase using goat polyclonal antienolase antibodies (C-19) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), but in our study these antibodies could not detect recombinant alpha-enolase by radioligand assay (data not shown).…”
Section: Discussioncontrasting
confidence: 59%
“…Because 9% of mothers who are seronegative at the time of fetal diagnosis later become seropositive, 10 and once they are detected, the antibodies permanently remain in the maternal serum, the mothers of all patients included in the present study systematically underwent, on inclusion, a screening for antibodies to soluble nuclear antigens 48-kd SSB/La, 52-kd SSA/Ro, and 60-kd SSA/Ro by use of previously described high-sensitivity, quantitative radioligand assays. 11 AV block was classified as congenital if it was diagnosed in utero, at birth, or during the first month of life and as childhood AV block if diagnosed between the first month and the fifteenth year of life. 12 The methodology and available data on the clinical characteristics of these patients have been reported previously.…”
Section: Clinical Investigationmentioning
confidence: 99%
“…Radioligand assay of the 75-kDa autoantigen reactivity was performed as described earlier 12 in the serum of each IPEX patient.…”
Section: Detection Of Anti-enterocyte Antibodiesmentioning
confidence: 99%